PCOS Rebranding to PMOS Signals New Clinical Focus on Metabolic Health Disparities

Summary

The transition from Polycystic Ovary Syndrome (PCOS) to Polycystic Metabolic Ovarian Syndrome (PMOS) aims to improve diagnosis rates among Black and Latina women. By centering metabolic dysfunction, the rebranding encourages earlier intervention for populations historically underserved by traditional diagnostic frameworks.

Positioning inside Endometriosis/PCOS and Diagnostics is being redrawn — the interesting question is which adjacent operators reprice. Look for follow-on moves from named investors, incumbents, and new entrants in the lane.

Sources

• OVUM Primary source